266 related articles for article (PubMed ID: 17947226)
1. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer.
Inaba H; Khan RB; Laningham FH; Crews KR; Pui CH; Daw NC
Ann Oncol; 2008 Jan; 19(1):178-84. PubMed ID: 17947226
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxicity of intrathecal methotrexate: MR imaging findings.
Sandoval C; Kutscher M; Jayabose S; Tenner M
AJNR Am J Neuroradiol; 2003 Oct; 24(9):1887-90. PubMed ID: 14561622
[TBL] [Abstract][Full Text] [Related]
3. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
Küker W; Bader P; Herrlinger U; Heckl S; Nägele T
J Neurooncol; 2005 May; 73(1):47-9. PubMed ID: 15933817
[TBL] [Abstract][Full Text] [Related]
4. Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome.
Rollins N; Winick N; Bash R; Booth T
AJNR Am J Neuroradiol; 2004; 25(10):1688-95. PubMed ID: 15569732
[TBL] [Abstract][Full Text] [Related]
5. [Hemiparesis in acute lymphoblastic leukemia].
Karremann M; von Komorowski G; Neumaier-Probst E; Dürken M
Radiologe; 2010 Aug; 50(8):706-10. PubMed ID: 20652214
[TBL] [Abstract][Full Text] [Related]
6. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings.
Dicuonzo F; Salvati A; Palma M; Lefons V; Lasalandra G; De Leonardis F; Santoro N
J Child Neurol; 2009 Aug; 24(8):1013-8. PubMed ID: 19307676
[TBL] [Abstract][Full Text] [Related]
7. Alternating hemiparesis and orolingual apraxia as manifestations of methotrexate neurotoxicity in a paediatric case of acute lymphoblastic leukaemia.
Yap SM; MacEneaney P; Ryan C; O'Toole O
BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27113788
[TBL] [Abstract][Full Text] [Related]
8. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.
Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H
Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
[TBL] [Abstract][Full Text] [Related]
10. Reversal of neurologic disturbances related to high-dose methotrexate by aminophylline.
Peyriere H; Poiree M; Cociglio M; Margueritte G; Hansel S; Hillaire-Buys D
Med Pediatr Oncol; 2001 Jun; 36(6):662-4. PubMed ID: 11344503
[No Abstract] [Full Text] [Related]
11. Recurrent intrathecal methotrexate induced neurotoxicity in an adolescent with acute lymphoblastic leukemia: Serial clinical and radiologic findings.
Brugnoletti F; Morris EB; Laningham FH; Patay Z; Pauley JL; Pui CH; Jeha S; Inaba H
Pediatr Blood Cancer; 2009 Feb; 52(2):293-5. PubMed ID: 18831032
[TBL] [Abstract][Full Text] [Related]
12. [Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].
Garcia-Puig M; Fons-Estupina MC; Rives-Sola S; Berrueco-Moreno R; Cruz-Martinez O; Campistol J
Rev Neurol; 2012 Jun; 54(12):712-8. PubMed ID: 22673947
[TBL] [Abstract][Full Text] [Related]
13. Dextromethorphan Administration on Day 0 and Day 7 for Secondary Prevention of Methotrexate-induced Neurotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Case Series.
Fustino NJ; Juhl K; Leister J
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e284-e287. PubMed ID: 31929386
[TBL] [Abstract][Full Text] [Related]
14. [Acute methotrexate-related neurotoxicity and pseudo-stroke syndrome].
Deneux V; Leboucq N; Saumet L; Haouy S; Akbaraly T; Sirvent N
Arch Pediatr; 2017 Dec; 24(12):1244-1248. PubMed ID: 29146215
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.
Haykin ME; Gorman M; van Hoff J; Fulbright RK; Baehring JM
J Neurooncol; 2006 Jan; 76(2):153-7. PubMed ID: 16411025
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.
Haykin M; Gorman M; van Hoff J; Fulbright R; Baehring J
J Neurooncol; 2006 Jan; 76(2):153-7. PubMed ID: 16132495
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and Management of Acute-Onset Hemiparesis in an Adolescent With Leukemia.
Subrahmanian KN; Shim YH; Shah MD; Tran BH; Stevens AM; Cruz AT
Pediatr Emerg Care; 2018 Mar; 34(3):e47-e50. PubMed ID: 27668914
[TBL] [Abstract][Full Text] [Related]
18. Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke.
Agarwal A; Vijay K; Thamburaj K; Ouyang T
Emerg Radiol; 2011 Aug; 18(4):345-7. PubMed ID: 21243392
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.
Vagace JM; Caceres-Marzal C; Jimenez M; Casado MS; de Murillo SG; Gervasini G
Am J Hematol; 2011 Jan; 86(1):98-101. PubMed ID: 21064136
[TBL] [Abstract][Full Text] [Related]
20. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]